d-Amphetamine and gamma-butyrolactone alteration of dopamine synthesis in the terminals of nigrostriatal and mesolimbic neurons. Possible role of various autoreceptor sensitivities.
D015107:4-Butyrolactone / Q000494:pharmacology*; D000818:Animals; D001058:Apomorphine / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects*; D003342:Corpus Striatum / Q000378:metabolism; D003913:Dextroamphetamine / Q000494:pharmacology*; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004298:Dopamine / Q000096:biosynthesis*; D005663:Furans / Q000494:pharmacology*; D006220:Haloperidol / Q000494:pharmacology; D008032:Limbic System / Q000378:metabolism; D008297:Male; D009474:Neurons / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000378:metabolism; D013378:Substantia Nigra / Q000378:metabolism
D005663:Furans; D011954:Receptors, Dopamine; D004295:Dihydroxyphenylalanine; D006220:Haloperidol; D001058:Apomorphine; D015107:4-Butyrolactone; D003913:Dextroamphetamine; D004298:Dopamine